Pediatric Cardiac Oxygenation Monitoring During Open-Heart Surgery
Official title: Spectroscopic Assessment of Myocardial Oxygenation Changes in Pediatric Heart Surgery
Run by Spectrocor · NCT07785141 · Data updated 2026-11-12
This study tests whether the SpectroCor Tissue Oxygenation Monitor and its Sensor can track heart tissue oxygen levels in children undergoing open-heart surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year to 17 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Spectrocor Industry-sponsored |
| Locations | 1 site (Helsinki, Uusimaa) |
| Status | Recruiting |
| Started | September 17, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | February 28, 2029 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT07785141 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children under 18 planned for elective open-heart surgery, with informed consent from parent/guardian.
✕Probably not a fit
Patients with consent limitations or those not experiencing meaningful intraoperative oxygenation changes may not derive direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this single-center observational study, up to 30 pediatric patients under 18 undergoing elective open-heart surgery will be monitored with the SpectroCor system to observe tissue oxygenation during the procedure. The study aims to determine if the monitor’s readings align with perioperative changes in myocardial perfusion and other clinical parameters, and to assess safety and usability. No control group is included, and real-world clinical practice is used to reflect routine use. Age categories follow the pediatric framework to account for developmental differences.
Why it matters
Potential benefit: If successful, the monitoring approach could help clinicians see real-time tissue oxygenation changes during surgery, potentially guiding intraoperative decisions.
How similar studies have gone: Previous device-based tissue oxygenation monitoring in pediatric settings has shown potential but remains exploratory for this application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Scheduled for open-heart surgery. * Age \<18 * Signed informed consent Exclusion Criteria: • Inability to provide informed consent
Where it's running
-
HUS New Childrens Hospital
Helsinki, Uusimaa, Finland Recruiting
Study contacts
- Principal investigator: Henri Haapanen, PhD — Helsinki University Hospital (HUS)
- Study coordinator: Kalle Kotilahti
- Email: kalle@spectrocor.com
- Phone: +358449016550
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
4-electrode tablet ECG vs standard 12-lead ECG: see which is faster and clearer
This study tests whether the 4-electrode DigitalCardio tablet ECG can record a full ECG faster and with comparable trace quality to a standard 12-lead ECG in adults with heart conditions.
-
Magnetocardiography in people with chest pain and non-obstructive heart arteries
This study uses magnetocardiography to see if it can help identify non-obstructive myocardial ischemia in adults with acute chest pain.
-
AI-assisted cardiac CT to predict coronary artery disease risk
This project will try using AI-enhanced heart CT scans to better predict future coronary events in adults who are already getting a clinical cardiac CT.
-
COMA.NET: Targeted treatment for coronary microcirculation problems
This trial will test whether tailoring medicines based on intracoronary microvascular testing improves quality of life for people with ischemia but no large artery blockages.
-
Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease
This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.